Total Antibody Detection ELISA
SARS-CoV-2 Clinical Diagnostic Kits – Quick and Effective
While molecular diagnostic techniques are a direct indicator of disease, serological techniques are an indirect diagnostic assay, which determines whether a person has overcome the disease and is therefore immunized. Thus, it is a complementary technique to PCR, especially in those cases where PCR gives a negative result.
The presence of specific antibodies to SARS-CoV-2 in patient samples indirectly proves that the individual has suffered from the infection.
The GSD INgezim COVID assays use the SARS-CoV-2 nucleoprotein (N protein) as the antigen for the detection of antibodies to SARS-CoV-2. The N protein is one of the most abundant early-onset proteins of the virus, as well as being highly immunogenic and therefore a good candidate antigen for the diagnosis of COVID19.
Total Antibody Detection ELISA Immunoassays
GSD INgezim COVID 19 DR
- Double recognition ELISA for the determination of total antibodies in serum samples. Capable of detecting all isotypes (IgG, IgM, and IgA) in a single sample
- Total incubation: 1 hour and 15 minutes
- No sample pre-dilution required
- Compatible with various open platform ELISA analyzers
GSD INgezym COVID 19 DR
Number of Tests
Double recognition ELISA for the determination of total antibodies in serum samples.